Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
Soma Compound with Codeine is a fixed-dose combination tablet containing aspirin (analgesic), carisoprodol (muscle relaxant), and codeine phosphate (opioid analgesic) administered orally. This product is indicated for the short-term management of acute musculoskeletal pain and discomfort. The combination works through multiple mechanisms: aspirin provides anti-inflammatory analgesia, carisoprodol relaxes skeletal muscles via CNS depression, and codeine enhances pain relief through opioid receptor agonism.
As LOE approaches, marketing focus likely shifting toward portfolio optimization and lifecycle extension strategies rather than growth investments.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Soma Compound with Codeine at this lifecycle stage offers limited growth trajectory but valuable experience in mature portfolio management, opioid compliance, and payer relations in a constrained regulatory environment. This role is best suited for professionals seeking operational excellence and managed markets expertise rather than launch-stage innovation.
Worked on SOMA COMPOUND W/ CODEINE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.